Clinical Trial Update: Randomized Study Comparing the Effect of Dasatinib and Imatinib on Malignant Stem Cells in Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 randomized study comparing dasatinib and imatinib on malignant stem cells in chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)
• Imatinib (imatinib)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: COMPLETED